BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7320156)

  • 1. Gel chromatography of heparin.
    Losito R; Gattiker H; Bilodeau G
    J Chromatogr; 1981 Nov; 226(1):61-7. PubMed ID: 7320156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin from the meadowsweet (Filipendula ulmaria) and its properties].
    Kudriashov BA; Ammosova IaM; Liapina LA; Osipova NN; Azieva LD; Liapin GIu; Basanova AV
    Izv Akad Nauk SSSR Biol; 1991; (6):939-43. PubMed ID: 1809785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on a highly potent anticoagulant anionic high molecular weight fraction isolated from porcine heparin.
    Sache E; Choay J; Fareed J
    Ann N Y Acad Sci; 1981; 370():627-43. PubMed ID: 6943973
    [No Abstract]   [Full Text] [Related]  

  • 4. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
    J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P; Strickland S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the separation of bovine heparin by strong anion exchange and by gel filtration chromatography.
    Rosenfeld L; Prior MT; Girardi LM
    Thromb Res; 1991 Oct; 64(2):203-11. PubMed ID: 1811339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiheparin effect of alpha 1-acid glycoprotein, evaluated by the activated partial thromboplastin time and by a factor Xa assay for heparin.
    Andersen P
    Haemostasis; 1980; 9(5):303-9. PubMed ID: 7409614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata).
    Cardilo-Reis L; Cavalcante MC; Silveira CB; Pavão MS
    Braz J Med Biol Res; 2006 Nov; 39(11):1409-15. PubMed ID: 17146553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method to determine the affinity of heparin to thrombin and antithrombin III on equilibrium gel permeation chromatography.
    Oshima G; Uchiyama H; Nagasawa K
    J Biochem; 1984 Oct; 96(4):1033-9. PubMed ID: 6520110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.
    Pejler G; Söderström K; Karlström A
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):507-13. PubMed ID: 8172612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring heparin anticoagulation in the acute phase response.
    Uprichard J; Manning RA; Laffan MA
    Br J Haematol; 2010 May; 149(4):613-9. PubMed ID: 20230412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian changes in anticoagulant effect of heparin infused at a constant rate.
    Decousus HA; Croze M; Levi FA; Jaubert JG; Perpoint BM; De Bonadona JF; Reinberg A; Queneau PM
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):341-4. PubMed ID: 3917812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.